Seppo Salminen

Scientific Opinion on the substantiation of health claims related to riboflavin (vitamin B2) and contribution to normal energy-yielding metabolism (ID 29, 35, 36, 42), contribution to normal metabolism of iron (ID 30, 37), maintenance of normal skin and mucous membranes (ID 31, 33), contribution to normal psychological functions (ID 32), maintenance of normal bone (ID 33), maintenance of normal teeth (ID 33), maintenance of normal hair (ID 33), maintenance of normal nails (ID 33), maintenance of normal vision (ID 39), maintenance of normal red blood cells (ID 40), reduction of tiredness and fatigue (ID 41), protection of DNA, proteins and lipids from oxidative damage (ID 207), and maintenance of the normal function of the nervous system (ID 213) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (2010)

Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J J ) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

"Scientific Opinion on the safety of ""Lentinus edodes extract"" (Lentinex®) as a Novel Food ingredient" (2010)

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Ota yhteyttä

Linkit

Asiantuntijuusalueet

Opetus

Tutkimus

Julkaisut

Järjestä:

"Scientific Opinion on the safety of ""Lentinus edodes extract"" (Lentinex®) as a Novel Food ingredient" (2010)